Validated by Research

---

At Brainmark, we believe in delivering insights that are not only cutting-edge but clinically and scientifically validated. That’s why our technology is grounded in the published research of our partner, Spectre Biotech, whose innovations in neurophysiological assessment have helped shape the tools we use today.

In a 2021 peer-reviewed study, researchers from Spectre Biotech and the University of Montreal demonstrated that even a single session of EEG neurofeedback can produce measurable improvements in attention and visual processing.

Using a next-generation, wireless EEG headset, 15 professional football players completed targeted neurofeedback training designed to boost peripheral visual attention — a critical skill in elite sport. The results were striking:

• +30% improvement in attentional performance immediately after training
   
• +20% retention of improvement after one month
   
• Setup time: under 1 minute
   

This study confirms the link between neural efficiency and sports performance, opening new doors for performance enhancement with a fast, user-friendly, non-invasive system.

📖 Source: Assadourian et al., 2021

Spectre Biotech’s work also extends to clinical populations. In a 2022 clinical review, EEG neurofeedback (EEG-NF) was shown to be a valuable tool in:

• Treating ADHD
   
• Aiding recovery from stroke (including spatial neglect and aphasia)
   
• Supporting patients with anxiety, burnout, and attention disorders
   

By modulating brain waves such as alpha and beta, EEG-NF protocols can restore balance to the brain’s attentional networks. With the latest dry-electrode technology, clinicians now have access to fast, portable, and intuitive tools for assessment and training — without the need for extensive setup or technical expertise.

📖 Source: Assadourian et al., 2022

A feasibility study conducted at the Centre Neuro-Psychiatrique Saint-Martin (Namur, Belgium) compared the Spectre Biotech wireless headset to a conventional EEG system.

Results showed:

• Significant reduction in setup and analysis time
   
• Increased patient comfort (no gel, no long prep times)
   
• Improved clinician productivity
   

The study concluded that Spectre’s dry-electrode EEG technology is a viable alternative in hospital settings — offering clinicians faster access to brain data while improving the patient experience.

📄 Internal feasibility report by Spectre Biotech

Thanks to our partner Spectre Biotech’s research and technology, Brainmark can offer:

• Clinically validated insights into mental performance
   
• Accessible and rapid testing for use in athletics, wellness, and healthcare
   
• Non-invasive, user-friendly neurotechnology suitable for daily use
   

Whether you represent  a medical facility, a sport federation, or a corporation's wellness program, a university, an insurance company, or the military, Brainmark delivers actionable data — backed by science.

Disclaimer: The research cited on this page was conducted independently by our partners at Spectre Biotech and affiliated academic institutions. Brainmark uses the technology and methodologies developed through these studies under authorized integration.